Tower Research Capital LLC TRC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tower Research Capital LLC TRC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 123.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,783 shares of the medical equipment provider's stock after buying an additional 16,436 shares during the period. Tower Research Capital LLC TRC's holdings in Intuitive Surgical were worth $15,546,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Bennett Selby Investments LP raised its holdings in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after acquiring an additional 17 shares during the last quarter. Onefund LLC raised its stake in shares of Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after purchasing an additional 18 shares during the last quarter. LVW Advisors LLC lifted its holdings in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. boosted its position in shares of Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after buying an additional 19 shares during the last quarter. Finally, FSM Wealth Advisors LLC grew its holdings in Intuitive Surgical by 3.7% during the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock worth $275,000 after buying an additional 19 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company's stock, valued at $2,793,033.06. The trade was a 60.72 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Jamie Samath sold 269 shares of the firm's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares in the company, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last ninety days. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded up $20.20 during trading hours on Thursday, reaching $508.13. The company had a trading volume of 2,282,203 shares, compared to its average volume of 1,610,102. The firm has a market cap of $180.99 billion, a PE ratio of 79.27, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a one year low of $367.39 and a one year high of $616.00. The business has a fifty day simple moving average of $515.40 and a 200 day simple moving average of $531.93.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the firm earned $1.50 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of analyst reports. Truist Financial cut their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday. CICC Research began coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 price target on the stock. Piper Sandler decreased their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Finally, Leerink Partners lifted their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $598.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.